- Home
- PRLD vs ICMB Comparison
PRLD vs ICMB Comparison
Compare PRLD & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- ICMB
- Stock Information
- Founded
- PRLD 2016
- ICMB 2012
- Country
- PRLD United States
- ICMB United States
- Employees
- PRLD N/A
- ICMB N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- ICMB Finance: Consumer Services
- Sector
- PRLD Health Care
- ICMB Finance
- Exchange
- PRLD Nasdaq
- ICMB Nasdaq
- Market Cap
- PRLD 50.1M
- ICMB 41.1M
- IPO Year
- PRLD 2020
- ICMB N/A
- Fundamental
- Price
- PRLD $0.89
- ICMB $2.70
- Analyst Decision
- PRLD Strong Buy
- ICMB
- Analyst Count
- PRLD 2
- ICMB 0
- Target Price
- PRLD $4.50
- ICMB N/A
- AVG Volume (30 Days)
- PRLD 137.5K
- ICMB 45.7K
- Earning Date
- PRLD 05-06-2025
- ICMB 05-13-2025
- Dividend Yield
- PRLD N/A
- ICMB 17.81%
- EPS Growth
- PRLD N/A
- ICMB N/A
- EPS
- PRLD N/A
- ICMB 0.82
- Revenue
- PRLD $7,000,000.00
- ICMB $20,996,189.00
- Revenue This Year
- PRLD N/A
- ICMB N/A
- Revenue Next Year
- PRLD N/A
- ICMB N/A
- P/E Ratio
- PRLD N/A
- ICMB $3.27
- Revenue Growth
- PRLD N/A
- ICMB N/A
- 52 Week Low
- PRLD $0.61
- ICMB $2.46
- 52 Week High
- PRLD $6.80
- ICMB $3.67
- Technical
- Relative Strength Index (RSI)
- PRLD 51.42
- ICMB 38.53
- Support Level
- PRLD $0.77
- ICMB $2.76
- Resistance Level
- PRLD $1.00
- ICMB $3.05
- Average True Range (ATR)
- PRLD 0.11
- ICMB 0.12
- MACD
- PRLD -0.01
- ICMB -0.02
- Stochastic Oscillator
- PRLD 37.18
- ICMB 3.57
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.